Previous close | 1.0000 |
Open | N/A |
Bid | N/A |
Ask | N/A |
Strike | N/A |
Expiry date | 2026-01-16 |
Day's range | 1.0000 - 1.0000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company. Before the transaction can proceed, the court overseeing the process must issue an approval order following a hearing currently scheduled for May 6, 2024.
Invitae (OTC: NVTA), a leading medical genetics company, today published its 2024 Environmental, Social and Governance (ESG) Report. This report provides a holistic view of the company's approach to ESG and its performance and progress through measurable data and metrics during the 2023 fiscal year.